Navigation Links
Local Research Foundation Achieves Milestone in Fight Against Cancer
Date:10/23/2008

CHRISTUS Stehlin Foundation for Cancer Research Develops Innovative

Anticancer Drug

HOUSTON, Oct. 23 /PRNewswire/ -- Almost everyone knows the devastation that cancer brings to families, workplaces and communities, and many Houstonians are aware of well-known local cancer treatment institutions. Few, however, may be familiar with the CHRISTUS Stehlin Foundation for Cancer Research, a nationally recognized leader in cancer research located in Houston, which recently achieved a milestone in their battle against cancer.

The CHRISTUS Stehlin Foundation recently received word from the Food and Drug Administration that CZ48, a promising anticancer drug they discovered and developed, was approved to begin Phase I (human) clinical trials. This is a large step in the journey to offer this potentially lifesaving drug to people suffering from cancer.

This is a remarkable accomplishment, since past records show that for every 5,000 to 10,000 oncology compounds discovered, only 250 make it to pre-clinical phases, and only five (one-tenth of one percent) are approved by the FDA for these human studies.

CZ48 is a derivative of extracts from a Chinese tree, the Camptotheca Acuminata, which more than 45 years ago showed potent anticancer activity against a type of mouse leukemia. The Stehlin Foundation has been researching cancer treatment with the Camptothecin family of compounds since 1988, and as a pioneer in the development of the Camptothecin family of drugs, has synthesized and tested more than 200 Camptothecin derivatives. In fact, the New York Academy of Science wrote, "Camptothecins can be envisioned as the ultimate anticancer drugs when fully developed."

The first phase of the trial has begun at the University of New Mexico Cancer Center in Albuquerque, N.M., and plans are also under way to offer the trial at Vanderbilt-Ingram Cancer Center in Nashville, Tenn. This phase of the clinical trial process
'/>"/>

SOURCE CHRISTUS Stehlin Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
2. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
3. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
4. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
5. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
6. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
7. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... FLORHAM PARK, N.J. , Aug. 21, 2014 ... specialty pharmacy group purchasing organization (GPO), is pleased ... (Aurora) to collaborate on a host of innovative ... will help Aurora deliver enhanced therapy management services ... Therapy Management (OTM) system. Aurora will ...
(Date:8/21/2014)... TORONTO , Aug. 21, 2014 /CNW/ - Bedrocan ... appointed three independent members to its Board of ... care experience of the company, a leading licensed ... . Internationally, Bedrocan has 13 years, experience ... patients in seven countries, including Canada. ...
(Date:8/21/2014)... 21, 2014   Auxilium Pharmaceuticals, Inc. ... company, today announced positive results from a randomized, ... (or CCH) for the treatment of edematous fibrosclerotic ... Phase 2a trial, all three doses of CCH ... an improvement in the appearance of cellulite as ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dealing with a ... challenging when the addict is a child. Adolescent substance abuse ... for a long time. But a new helpline is now ... find professional youth rehab for something like a teen ... was designed to help make a positive impact in the ...
(Date:8/22/2014)... According to the market research report "Blind ... (ACC) System Market for Passenger Cars; by Geography ... by MarketsandMarkets, classifies and defines the automotive BSD ... and value. The report highlights potential growth opportunities ... review of the market drivers, restrains, growth indicators, ...
(Date:8/21/2014)... 2014 The natural loss of collagen, or ... and sagging of skin. Using products to boost collagen ... the body has lost about 15% of it collagen production ... Kathy Heshelow, founder of Sublime Beauty®. "Collagen holds up ... well, we know what happens." , Collagen in fact makes ...
(Date:8/21/2014)... 2014 Local agencies in the U.S. ... for specific protection plans, according to released insurer data. ... quote life insurance from local agencies using its tool ... that appear inside of the national system are licensed ... price reviews this year. Adults who enter the search ...
(Date:8/21/2014)... Lake City, Utah (PRWEB) August 21, 2014 ... ) is pleased to announce the addition of ... over 30 years of healthcare management experience, Gillespie ... His experience includes multiple executive management positions with ... Most recently Kerry served as President of Triad ...
Breaking Medicine News(10 mins):Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2
... all centers performed as well, nearly 153,000 lives might ... (HealthDay News) The top-rated U.S. hospitals have a ... to a study released Tuesday by HealthGrades, an independent ... of about 41 million Medicare patients treated at the ...
... The Centene Foundation for Quality,Healthcare announced today that ... Women,s Wellness, Inc. (CBWW) to support Journey to Wellness, ... among black women. , Through ... drama, movie nights with discussion sessions, and tea parties ...
... 27 Simbionix, the world,s,leading developer of medical ... Cerebral Interventions and Cardiac Rhythm,Management. , ... Simbionix,s commitment to,enriching the content of its training ... The Cardiac Rhythm Management module ...
... benefits managers, and even government officials are using ... according to a report to be published in ... , Daniel Lorence of Penn State Center for ... the phenomenal growth of the internet as an ...
... pylori , a Gram-negative, flagellated, microaerophilic bacterium, can ... is widespread throughout the world, and is present ... with 80% in developing countries and 20-50% in ... H. pylori induces a local immune response ...
... Jan. 27 The Risk Management and ... clinical risk management,practices and patient safety programs ... a three-year license partnership with Salus Global,Corporation ... performance,improvement program to U.S. hospitals and health ...
Cached Medicine News:Health News:America's Top Hospitals Cut Patient Death Rate 27% 2Health News:Centene Foundation for Quality Healthcare Awards Grant to Center for Black Women's Wellness 2Health News:Simbionix Releases Two New Simulation Modules 2Health News:Pharmaceutical disobedience 2Health News:Helicobacter pylori can multiply in autophagic vesicles 2Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 2Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 3Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: